The company, established in 2005, focuses on generic pharmaceuticals, particularly in niche segments like oncology, CNS, gastroenterology, and anti-diabetics. Specializing in the development of finished formulations and product dossiers, the company prepares for upcoming patent expirations to expand its market presence. With state-of-the-art, WHO-GMP certified manufacturing facilities across the country, the company supplies high-quality formulations globally under its own license and through contract manufacturing. Committed to improving quality of life, the company emphasizes innovation and consistency in its product offerings, aiming to meet the specific needs of diverse markets worldwide.

This CTD dossier owner and manufacturer is a global producer of pharmaceutical and biotechnology products, specializing in a wide range of therapeutic areas including oncology, infectious diseases (antibiotics, anti-retrovirals, anti-tuberculars), and central nervous system disorders. They offer various dosage forms such as prescription medications, over-the-counter drugs, and medical devices. The company leverages its expertise in API manufacturing and finished product production through partnerships with PIC/S certified facilities. They hold patents and marketing authorizations across multiple regions like the EU and North America. Additionally, they provide consulting, marketing, manufacturing, and technology transfer services within the pharmaceutical industry.

This CTD dossier owner and manufacturer specializes in oncology medications, with a focus on providing high-quality products that meet international pharmaceutical standards. They operate dedicated oncology units certified under both EU GMP and WHO GMP guidelines to ensure consistent quality across their range of products. Their key therapy areas likely revolve around cancer treatment, and they offer various dosage forms to address diverse patient needs. The company is committed to regulatory compliance, working closely with local and international bodies to maintain approvals for all their medications.